333 related articles for article (PubMed ID: 30081709)
21. A Chimeric protein of CFA/I, CS6 subunits and LTB/STa toxoid protects immunized mice against enterotoxigenic Escherichia coli.
Zeinalzadeh N; Salmanian AH; Goujani G; Amani J; Ahangari G; Akhavian A; Jafari M
Microbiol Immunol; 2017 Jul; 61(7):272-279. PubMed ID: 28543534
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity of recombinant Lactobacillus casei-expressing F4 (K88) fimbrial adhesin FaeG in conjunction with a heat-labile enterotoxin A (LTAK63) and heat-labile enterotoxin B (LTB) of enterotoxigenic Escherichia coli as an oral adjuvant in mice.
Yu M; Qi R; Chen C; Yin J; Ma S; Shi W; Wu Y; Ge J; Jiang Y; Tang L; Xu Y; Li Y
J Appl Microbiol; 2017 Feb; 122(2):506-515. PubMed ID: 27860074
[TBL] [Abstract][Full Text] [Related]
23. Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study.
Lundgren A; Bourgeois L; Carlin N; Clements J; Gustafsson B; Hartford M; Holmgren J; Petzold M; Walker R; Svennerholm AM
Vaccine; 2014 Dec; 32(52):7077-84. PubMed ID: 25444830
[TBL] [Abstract][Full Text] [Related]
24. A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization.
Bernstein DI; Pasetti MF; Brady R; Buskirk AD; Wahid R; Dickey M; Cohen M; Baughman H; El-Khorazaty J; Maier N; Sztein MB; Baqar S; Bourgeois AL
Vaccine; 2019 Jan; 37(4):602-611. PubMed ID: 30563789
[TBL] [Abstract][Full Text] [Related]
25. Passive antibodies derived from intramuscularly immunized toxoid fusion 3xSTa
Nandre RM; Duan Q; Wang Y; Zhang W
Vaccine; 2017 Jan; 35(4):552-556. PubMed ID: 28017433
[TBL] [Abstract][Full Text] [Related]
26. Antibodies derived from a toxoid MEFA (multiepitope fusion antigen) show neutralizing activities against heat-labile toxin (LT), heat-stable toxins (STa, STb), and Shiga toxin 2e (Stx2e) of porcine enterotoxigenic Escherichia coli (ETEC).
Rausch D; Ruan X; Nandre R; Duan Q; Hashish E; Casey TA; Zhang W
Vet Microbiol; 2017 Apr; 202():79-89. PubMed ID: 26878972
[TBL] [Abstract][Full Text] [Related]
27. Review on pathogenicity mechanism of enterotoxigenic Escherichia coli and vaccines against it.
Mirhoseini A; Amani J; Nazarian S
Microb Pathog; 2018 Apr; 117():162-169. PubMed ID: 29474827
[TBL] [Abstract][Full Text] [Related]
28. Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study.
McKenzie R; Bourgeois AL; Frech SA; Flyer DC; Bloom A; Kazempour K; Glenn GM
Vaccine; 2007 May; 25(18):3684-91. PubMed ID: 17313998
[TBL] [Abstract][Full Text] [Related]
29. Outer membrane vesicles induce immune responses to virulence proteins and protect against colonization by enterotoxigenic Escherichia coli.
Roy K; Hamilton DJ; Munson GP; Fleckenstein JM
Clin Vaccine Immunol; 2011 Nov; 18(11):1803-8. PubMed ID: 21900530
[TBL] [Abstract][Full Text] [Related]
30. Immunogenicity and Protective Efficacy against Enterotoxigenic Escherichia coli Colonization following Intradermal, Sublingual, or Oral Vaccination with EtpA Adhesin.
Luo Q; Vickers TJ; Fleckenstein JM
Clin Vaccine Immunol; 2016 Jul; 23(7):628-37. PubMed ID: 27226279
[TBL] [Abstract][Full Text] [Related]
31. Genetic fusions of a CFA/I/II/IV MEFA (multiepitope fusion antigen) and a toxoid fusion of heat-stable toxin (STa) and heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC) retain broad anti-CFA and antitoxin antigenicity.
Ruan X; Sack DA; Zhang W
PLoS One; 2015; 10(3):e0121623. PubMed ID: 25803825
[TBL] [Abstract][Full Text] [Related]
32. Genetic fusions of heat-labile (LT) and heat-stable (ST) toxoids of porcine enterotoxigenic Escherichia coli elicit neutralizing anti-LT and anti-STa antibodies.
Zhang W; Zhang C; Francis DH; Fang Y; Knudsen D; Nataro JP; Robertson DC
Infect Immun; 2010 Jan; 78(1):316-25. PubMed ID: 19858307
[TBL] [Abstract][Full Text] [Related]
33. Intradermal or Sublingual Delivery and Heat-Labile Enterotoxin Proteins Shape Immunologic Responses to a CFA/I Fimbria-Derived Subunit Antigen Vaccine against Enterotoxigenic Escherichia coli.
Maciel M; Bauer D; Baudier RL; Bitoun J; Clements JD; Poole ST; Smith MA; Kaminski RW; Savarino SJ; Norton EB
Infect Immun; 2019 Nov; 87(11):. PubMed ID: 31427449
[TBL] [Abstract][Full Text] [Related]
34. [Advances in new vaccines against human enterotoxigenic Escherichia coli--A review].
Xia P; Meng X; Zhu G
Wei Sheng Wu Xue Bao; 2016 Feb; 56(2):198-208. PubMed ID: 27373068
[TBL] [Abstract][Full Text] [Related]
35. Cooperative role of antibodies against heat-labile toxin and the EtpA Adhesin in preventing toxin delivery and intestinal colonization by enterotoxigenic Escherichia coli.
Roy K; Hamilton DJ; Fleckenstein JM
Clin Vaccine Immunol; 2012 Oct; 19(10):1603-8. PubMed ID: 22875600
[TBL] [Abstract][Full Text] [Related]
36. Development of live attenuated bacterial vaccines targeting Escherichia coli heat-labile and heat-stable enterotoxins.
Zhu C; Setty P; Boedeker EC
Vet Microbiol; 2017 Apr; 202():72-78. PubMed ID: 28527491
[TBL] [Abstract][Full Text] [Related]
37. Gene fusion and expression of heat-labile and heat-stable enterotoxins of enterotoxigenic Escherichia coli.
Bing X; Zhaoshan Z; Shuqin L; Dong S; Cuifen H
Chin J Biotechnol; 1999; 15(4):225-30. PubMed ID: 11037947
[TBL] [Abstract][Full Text] [Related]
38. Characterization of immunological cross-reactivity between enterotoxigenic Escherichia coli heat-stable toxin and human guanylin and uroguanylin.
Taxt AM; Diaz Y; Bacle A; Grauffel C; Reuter N; Aasland R; Sommerfelt H; Puntervoll P
Infect Immun; 2014 Jul; 82(7):2913-22. PubMed ID: 24778111
[TBL] [Abstract][Full Text] [Related]
39. Design and characterization of a chimeric multiepitope construct containing CfaB, heat-stable toxoid, CssA, CssB, and heat-labile toxin subunit B of enterotoxigenic Escherichia coli: a bioinformatic approach.
Zeinalzadeh N; Salmanian AH; Ahangari G; Sadeghi M; Amani J; Bathaie SZ; Jafari M
Biotechnol Appl Biochem; 2014; 61(5):517-27. PubMed ID: 24372617
[TBL] [Abstract][Full Text] [Related]
40. Construction of Bifidobacterium infantis as a live oral vaccine that expresses antigens of the major fimbrial subunit (CfaB) and the B subunit of heat-labile enterotoxin (LTB) from enterotoxigenic Escherichia coli.
Ma Y; Luo Y; Huang X; Song F; Liu G
Microbiology (Reading); 2012 Feb; 158(Pt 2):498-504. PubMed ID: 22053005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
